Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Carboxylic Acids to Methylesters: Alkylation using Diazomethane01:33

Carboxylic Acids to Methylesters: Alkylation using Diazomethane

Carboxylic acids react with diazomethane in an ether solvent via alkylation at the carboxylate oxygen atom to give methyl esters of the corresponding acid with excellent yields.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fragment-based discovery of pyrazole-5-carboxamide derivatives as ALK inhibitors against non-small cell lung cancer.

Bioorganic chemistry·2026
Same author

TRK inhibitors in cancer therapeutics: Recent advances and future perspectives.

Bioorganic chemistry·2026
Same author

A cyclodextrin-deep eutectic solvent-based dispersive liquid-liquid microextraction method for quantitative determination of small molecules in fresh-cut Codonopsis Radix.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2025
Same author

Discovery and structural-activity relationship of N-benzyl-2-fluorobenzamides as EGFR/HDAC3 dual-target inhibitors for the treatment of triple-negative breast cancer.

Bioorganic & medicinal chemistry letters·2025
Same author

[Effects of drought stress training on polysaccharide accumulation and drought resistance of Codonopsis pilosula].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2025
Same author

Anti-hypoxia polyacetylenes and sesquiterpenoids from <i>Codonopsis pilosula</i> (Franch.) Nannf.

Natural product research·2025

Related Experiment Video

Updated: Jul 7, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

[DNA methylation and prostate cancer].

Shui-Gen Zhou1, Ying-Hao Sun, Jian-Ping Gao

  • 1Department of Urology, Nanjing General Hospital of Nanjing Military Command, PLA, Nanjing, Jiangsu 210002, China.

Zhonghua Nan Ke Xue = National Journal of Andrology
|February 21, 2008
PubMed
Summary

DNA methylation, a key process in cancer, is altered in prostate cancer and its precursor lesions. Studying these DNA methylation changes offers new avenues for prostate cancer diagnosis and treatment.

More Related Videos

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Experiment Videos

Last Updated: Jul 7, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Molecular Oncology

Context:

  • DNA methylation is a frequent epigenetic modification observed in various cancers, including prostate cancer.
  • Aberrant DNA methylation patterns are implicated in the initiation and progression of malignancies.
  • Genes involved in critical cellular functions, like DNA damage repair, are frequently hypermethylated in prostate cancer.

Purpose:

  • To investigate the role and patterns of DNA methylation in prostate cancer and its precursor lesions.
  • To explore the potential of DNA methylation as a biomarker for prostate cancer diagnosis and prognosis.

Summary:

  • DNA methylation is prevalent in prostate cancer, affecting genes crucial for cell processes like DNA repair.
  • Premalignant lesions, such as prostatic intraepithelial neoplasia, also exhibit DNA methylation changes, albeit to a lesser degree than in established cancer.
  • These findings highlight the significance of DNA methylation in prostate carcinogenesis.

Impact:

  • Understanding DNA methylation in prostate cancer can lead to novel strategies for early detection.
  • Aberrant methylation patterns may serve as prognostic indicators for patient outcomes.
  • Targeting DNA methylation pathways presents a potential therapeutic approach for prostate cancer treatment.